NCT00021047: Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor |
|
|
| Completed | 1/2 | | US | capecitabine, carboplatin, epirubicin hydrochloride | National Institutes of Health Clinical Center (CC), National Cancer Institute (NCI) | Esophageal Cancer, Extrahepatic Bile Duct Cancer, Gastric Cancer, Head and Neck Cancer, Liver Cancer, Unspecified Adult Solid Tumor, Protocol Specific | | 06/04 | | |